The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

United Therapeutics Corp

Nasdaq: UTHR
Last

(U.S.) $119.74

Today's change+0.42 +0.35%
Updated February 10 4:00 PM EST. Delayed by at least 15 minutes.
 

United Therapeutics Corp

Nasdaq: UTHR
Last

(U.S.) $119.74

Today's change+0.42 +0.35%
Updated February 10 4:00 PM EST. Delayed by at least 15 minutes.

United Therapeutics Corp up (U.S.)$0.42

United Therapeutics Corp closed up Wednesday by (U.S.)$0.42 or 0.35% to (U.S.)$119.74. Over the last five days, shares have lost 2.47% and are down 23.54% for the last year to date. This security has underperformed the S&P 500 by 7.89% during the last year.

Key company metrics

  • Open(U.S.) $120.83
  • Previous close(U.S.) $119.32
  • High(U.S.) $126.08
  • Low(U.S.) $119.59
  • Bid / Ask-- / --
  • YTD % change-23.54%
  • Volume706,757
  • Average volume (10-day)806,277
  • Average volume (1-month)764,277
  • Average volume (3-month)723,542
  • 52-week range(U.S.) $113.20 to (U.S.) $190.29
  • Beta1.69
  • Trailing P/E9.24×
  • P/E 1 year forward8.99×
  • Forward PEG0.42×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $12.96
Updated February 10 4:00 PM EST. Delayed by at least 15 minutes.
S&P TSX0.79%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2015Q2/2015Q1/2015Q4/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014
Revenue386347328346
Total other revenue--------
Total revenue386347328346
Gross profit379331307331
Total cost of revenue7162116
Total operating expense-1175342168
Selling / general / administrative-1711021181
Research & development104911071
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income387172-15179
Interest income (expense), net non-operating-1-1-2-4
Gain (loss) on sale of assets350------
Other--------
Income before tax737168-17175
Income after tax46499-17116
Income tax, total27269059
Net income46499-17116
Total adjustments to net income--------
Net income before extra. items46499-17116
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items46499-17116
Inc. avail. to common incl. extra. items46499-17116
Diluted net income46499-17116
Dilution adjustment--------
Diluted weighted average shares50524754
Diluted EPS excluding extraordinary itemsvalue per share9.241.91-0.362.17
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share4.851.91-0.362.17